Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus Apotel for postoperative pain control after emergency laparotomy
IRCT20191104045328N24Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Remifentanil pain pump with Apotel pain pump (2 arms). Primary endpoints: Pain intensity, Side effects and 1 more. Started Aug 2024; status: completed.
02
Drugs
remifentanilacetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20191104045328N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N24.